New biomedical approaches for sexually transmitted infection prevention

Vaccines and microbicides

Richard Rupp, Lawrence R. Stanberry, Susan L. Rosenthal

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

STIs are a major global health problem. Biomedical strategies are under development that will help prevent these infections. Vaccines against C trachomatis and N gonorrhoeae are in early stages of development. Stage-III trials are underway on prophylactic vaccines for HPV and HSV-2. Strategies focused on immunizing only high-risk individuals are unlikely to stem the tide of STIs. Approaches to widespread immunization require acceptance of such vaccines by health care providers, institutions providing funding, parents, and adolescents. Microbicides offer a female-controlled method for protection from STIs. They use many strategies to prevent infection. These products are at various stages of development. It seems that young women and teenagers would be interested in using microbicides. Correct and consistent use of microbicides will require taking women's preferences into account during product development and marketing.

Original languageEnglish (US)
Pages (from-to)393-407
Number of pages15
JournalAdolescent Medicine Clinics
Volume15
Issue number2
DOIs
StatePublished - Jun 2004

Fingerprint

Sexually Transmitted Diseases
Anti-Infective Agents
Vaccines
Papillomavirus Vaccines
Human Herpesvirus 2
Gonorrhea
Infection
Marketing
Health Personnel
Immunization
Parents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

New biomedical approaches for sexually transmitted infection prevention : Vaccines and microbicides. / Rupp, Richard; Stanberry, Lawrence R.; Rosenthal, Susan L.

In: Adolescent Medicine Clinics, Vol. 15, No. 2, 06.2004, p. 393-407.

Research output: Contribution to journalArticle

Rupp, Richard ; Stanberry, Lawrence R. ; Rosenthal, Susan L. / New biomedical approaches for sexually transmitted infection prevention : Vaccines and microbicides. In: Adolescent Medicine Clinics. 2004 ; Vol. 15, No. 2. pp. 393-407.
@article{c09912dc327f4daea303a24329f7ac39,
title = "New biomedical approaches for sexually transmitted infection prevention: Vaccines and microbicides",
abstract = "STIs are a major global health problem. Biomedical strategies are under development that will help prevent these infections. Vaccines against C trachomatis and N gonorrhoeae are in early stages of development. Stage-III trials are underway on prophylactic vaccines for HPV and HSV-2. Strategies focused on immunizing only high-risk individuals are unlikely to stem the tide of STIs. Approaches to widespread immunization require acceptance of such vaccines by health care providers, institutions providing funding, parents, and adolescents. Microbicides offer a female-controlled method for protection from STIs. They use many strategies to prevent infection. These products are at various stages of development. It seems that young women and teenagers would be interested in using microbicides. Correct and consistent use of microbicides will require taking women's preferences into account during product development and marketing.",
author = "Richard Rupp and Stanberry, {Lawrence R.} and Rosenthal, {Susan L.}",
year = "2004",
month = "6",
doi = "10.1016/j.admecli.2004.02.010",
language = "English (US)",
volume = "15",
pages = "393--407",
journal = "Adolescent Medicine",
issn = "1934-4287",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - New biomedical approaches for sexually transmitted infection prevention

T2 - Vaccines and microbicides

AU - Rupp, Richard

AU - Stanberry, Lawrence R.

AU - Rosenthal, Susan L.

PY - 2004/6

Y1 - 2004/6

N2 - STIs are a major global health problem. Biomedical strategies are under development that will help prevent these infections. Vaccines against C trachomatis and N gonorrhoeae are in early stages of development. Stage-III trials are underway on prophylactic vaccines for HPV and HSV-2. Strategies focused on immunizing only high-risk individuals are unlikely to stem the tide of STIs. Approaches to widespread immunization require acceptance of such vaccines by health care providers, institutions providing funding, parents, and adolescents. Microbicides offer a female-controlled method for protection from STIs. They use many strategies to prevent infection. These products are at various stages of development. It seems that young women and teenagers would be interested in using microbicides. Correct and consistent use of microbicides will require taking women's preferences into account during product development and marketing.

AB - STIs are a major global health problem. Biomedical strategies are under development that will help prevent these infections. Vaccines against C trachomatis and N gonorrhoeae are in early stages of development. Stage-III trials are underway on prophylactic vaccines for HPV and HSV-2. Strategies focused on immunizing only high-risk individuals are unlikely to stem the tide of STIs. Approaches to widespread immunization require acceptance of such vaccines by health care providers, institutions providing funding, parents, and adolescents. Microbicides offer a female-controlled method for protection from STIs. They use many strategies to prevent infection. These products are at various stages of development. It seems that young women and teenagers would be interested in using microbicides. Correct and consistent use of microbicides will require taking women's preferences into account during product development and marketing.

UR - http://www.scopus.com/inward/record.url?scp=3142634642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142634642&partnerID=8YFLogxK

U2 - 10.1016/j.admecli.2004.02.010

DO - 10.1016/j.admecli.2004.02.010

M3 - Article

VL - 15

SP - 393

EP - 407

JO - Adolescent Medicine

JF - Adolescent Medicine

SN - 1934-4287

IS - 2

ER -